The efficacy of midline catheters—a prospective, randomized, active-controlled study

ObjectivesThis study was performed to investigate whether an intravenous (IV) strategy based on new-generation midline catheters is efficacious alternative a conventional IV consisting of peripheral venous and central catheters, for patients needing therapy exceeding 5 days.MethodsThis prospective, randomized, controlled study. Patients requiring more than days treatment were randomized either catheter-based or strategy. The primary endpoint the composite insertion catheter (CVC) need four (PVC) insertions. secondary outcomes included dwell times reasons premature removal.ResultsOne hundred twenty included. fraction receiving PVCs having CVC inserted 12/58 (21%) in group versus 38/58 (66%) (p < 0.001); number needed treat 2.2. median overall time 7 (range 0–60 days) 4 0–84 = 0.002).ConclusionIn therapy, reduced PVCs.